ANAVEX LIFE SCIENCES CORP. Other Income and Expense
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Other Income and Expense of $1.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for the quarter ending 2026-06-30 was $1.09M, a 10.61% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for the quarter ending 2026-03-31 was $1.15M, a 12.98% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for the quarter ending 2025-12-31 was $1.12M, a 24.44% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for the quarter ending 2025-09-30 was $1.02M, a 61.64% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for fiscal 2025 was $5.03M, a 49.05% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for fiscal 2024 was $9.88M, a 19.58% increase from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for fiscal 2023 was $8.26M, a 145.34% increase from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. nonoperating income (expense) for fiscal 2022 was $3.37M, a 22.82% decline from fiscal 2021.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 3 month as first filed | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 6 month as first filed | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 9 month as first filed | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed | Nonoperating Income (Expense) 122 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.09M 10-Q · filed 2026-08-28 | $2.23M derived: sum of 2 quarters · filed 2026-08-28 | $3.35M 10-Q · filed 2026-08-28 | $4.37M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2026-03-31 | $1.15M 10-Q · filed 2026-08-28 | $2.27M 10-Q · filed 2026-08-28 | $3.28M derived: sum of 3 quarters · filed 2026-08-28 | $4.50M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2025-12-31 | $1.12M 10-Q · filed 2026-02-09 | $2.14M derived: sum of 2 quarters · filed 2026-08-28 | $3.35M derived: sum of 3 quarters · filed 2026-08-28 | $4.67M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2025-09-30 | $1.02M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $2.23M derived: sum of 2 quarters · filed 2026-08-28 | $3.55M derived: sum of 3 quarters · filed 2026-08-28 | $5.03M 10-K/A · filed 2026-08-28 | |||||
| 2025-06-30 | $1.22M 10-Q · filed 2026-08-28 | $2.53M derived: sum of 2 quarters · filed 2026-08-28 | $4.01M 10-Q · filed 2026-08-28 | $6.67M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2025-03-31 | $1.32M 10-Q · filed 2026-08-28 | $2.80M 10-Q · filed 2026-08-28 | $5.45M derived: sum of 3 quarters · filed 2026-08-28 | $7.84M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2024-12-31 | $1.48M 10-Q · filed 2026-02-09 | $4.13M derived: sum of 2 quarters · filed 2026-08-28 | $6.52M derived: sum of 3 quarters · filed 2026-08-28 | $8.60M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2024-09-30 | $2.65M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $5.04M derived: sum of 2 quarters · filed 2026-08-28 | $7.12M derived: sum of 3 quarters · filed 2026-08-28 | $9.88M 10-K/A · filed 2026-08-28 | |||||
| 2024-06-30 | $2.39M 10-Q · filed 2025-08-12 | $2.45M 10-Q · filed 2024-08-06 | $4.47M derived: sum of 2 quarters · filed 2025-08-12 | $7.22M 10-Q · filed 2025-08-12 | $7.28M 10-Q · filed 2024-08-06 | $9.66M derived: sum of 4 quarters · filed 2026-08-28 | |||
| 2024-03-31 | $2.08M 10-Q · filed 2025-05-13 | $4.83M 10-Q · filed 2025-05-13 | $7.28M derived: sum of 3 quarters · filed 2026-08-28 | $9.57M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2023-12-31 | $2.76M 10-Q · filed 2025-02-12 | $5.20M derived: sum of 2 quarters · filed 2026-08-28 | $7.49M derived: sum of 3 quarters · filed 2026-08-28 | $8.62M derived: sum of 4 quarters · filed 2026-08-28 | |||||
| 2023-09-30 | $2.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $4.73M derived: sum of 2 quarters · filed 2026-08-28 | $5.87M derived: sum of 3 quarters · filed 2026-08-28 | $8.26M 10-K/A · filed 2026-08-28 | |||||
| 2023-06-30 | $2.29M 10-Q · filed 2024-08-06 | $2.29M 10-Q · filed 2023-08-08 | $3.42M derived: sum of 2 quarters · filed 2024-08-06 | $5.82M 10-Q · filed 2024-08-06 | $5.82M 10-Q · filed 2023-08-08 | $7.02M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $1.13M 10-Q · filed 2024-05-09 | $1.13M 10-Q · filed 2023-05-09 | $3.52M 10-Q · filed 2024-05-09 | $3.52M 10-Q · filed 2023-05-09 | $4.73M derived: sum of 3 quarters · filed 2024-05-09 | $4.91M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $2.39M 10-Q · filed 2024-02-07 | $2.39M 10-Q · filed 2023-02-07 | $3.60M derived: sum of 2 quarters · filed 2024-02-07 | $3.78M derived: sum of 3 quarters · filed 2024-02-07 | $4.89M derived: sum of 4 quarters · filed 2024-02-07 | ||||
| 2022-09-30 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $1.38M derived: sum of 2 quarters · filed 2023-11-27 | $2.49M derived: sum of 3 quarters · filed 2023-11-27 | $3.37M 10-K · filed 2023-11-27 | $3.37M 10-K · filed 2022-11-28 | ||||
| 2022-06-30 | $179.80K 10-Q · filed 2023-08-08 | $1.29M derived: sum of 2 quarters · filed 2023-08-08 | $2.16M 10-Q · filed 2023-08-08 | $2.84M derived: sum of 4 quarters · filed 2023-11-27 | |||||
| 2022-03-31 | $1.11M 10-Q · filed 2023-05-09 | $1.98M 10-Q · filed 2023-05-09 | $2.66M derived: sum of 3 quarters · filed 2023-11-27 | $3.92M derived: sum of 4 quarters · filed 2023-11-27 | |||||
| 2021-12-31 | $871.00K 10-Q · filed 2023-02-07 | $1.55M derived: sum of 2 quarters · filed 2023-11-27 | $2.81M derived: sum of 3 quarters · filed 2023-11-27 | $3.63M derived: sum of 4 quarters · filed 2023-11-27 | |||||
| 2021-09-30 | $676.74K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $1.93M derived: sum of 2 quarters · filed 2023-11-27 | $2.76M derived: sum of 3 quarters · filed 2023-11-27 | $4.36M 10-K · filed 2023-11-27 | $4.36M 10-K · filed 2021-11-24 | ||||
| 2021-06-30 | $1.26M 10-Q · filed 2022-08-09 | $2.08M derived: sum of 2 quarters · filed 2022-08-09 | $3.68M 10-Q · filed 2022-08-09 | $5.24M derived: sum of 4 quarters · filed 2022-11-28 | |||||
| 2021-03-31 | $826.35K 10-Q · filed 2022-05-10 | $2.43M 10-Q · filed 2022-05-10 | $3.98M derived: sum of 3 quarters · filed 2022-11-28 | $5.60M derived: sum of 4 quarters · filed 2022-11-28 | |||||
| 2020-12-31 | $1.60M 10-Q · filed 2022-02-09 | $3.15M derived: sum of 2 quarters · filed 2022-11-28 | $4.78M derived: sum of 3 quarters · filed 2022-11-28 | $5.31M derived: sum of 4 quarters · filed 2022-11-28 | |||||
| 2020-09-30 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $3.18M derived: sum of 2 quarters · filed 2022-11-28 | $3.71M derived: sum of 3 quarters · filed 2022-11-28 | $4.83M 10-K · filed 2022-11-28 | |||||
| 2020-06-30 | $1.62M 10-Q · filed 2021-08-12 | $2.16M derived: sum of 2 quarters · filed 2021-08-12 | $3.28M 10-Q · filed 2021-08-12 | $4.03M derived: sum of 4 quarters · filed 2021-08-12 | |||||
| 2020-03-31 | $536.49K 10-Q · filed 2021-05-13 | $1.65M 10-Q · filed 2021-05-13 | $2.40M derived: sum of 3 quarters · filed 2021-05-13 | $3.04M derived: sum of 4 quarters · filed 2021-05-13 | |||||
| 2019-12-31 | $1.12M 10-Q · filed 2021-02-16 | $1.86M derived: sum of 2 quarters · filed 2021-02-16 | $2.51M derived: sum of 3 quarters · filed 2021-02-16 | $3.45M derived: sum of 4 quarters · filed 2021-02-16 | |||||
| 2019-09-30 | $745.92K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $1.39M derived: sum of 2 quarters · filed 2020-12-28 | $2.33M derived: sum of 3 quarters · filed 2020-12-28 | $2.89M 10-K · filed 2020-12-28 | |||||
| 2019-06-30 | $644.55K 10-Q · filed 2020-08-06 | $92.21K 10-Q · filed 2019-08-07 | $1.59M derived: sum of 2 quarters · filed 2020-08-06 | $2.15M 10-Q · filed 2020-08-06 | $421.23K 10-Q · filed 2019-08-07 | $2.48M derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-31 | $941.18K 10-Q · filed 2020-05-07 | $180.19K 10-Q · filed 2019-05-09 | $1.50M 10-Q · filed 2020-05-07 | $329.01K 10-Q · filed 2019-05-09 | $1.84M derived: sum of 3 quarters · filed 2020-05-07 | $3.60M derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | $562.50K 10-Q · filed 2020-02-06 | $148.82K 10-Q · filed 2019-02-07 | $894.59K derived: sum of 2 quarters · filed 2020-02-06 | $2.66M derived: sum of 3 quarters · filed 2020-02-06 | $2.67M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-09-30 | $332.09K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $2.10M derived: sum of 2 quarters · filed 2019-12-16 | $2.11M derived: sum of 3 quarters · filed 2019-12-16 | $2.15M 10-K · filed 2019-12-16 | $1.95M 10-K · filed 2018-12-12 | ||||
| 2018-06-30 | $1.77M 10-Q · filed 2019-08-07 | $1.78M derived: sum of 2 quarters · filed 2019-08-07 | $1.82M 10-Q · filed 2019-08-07 | $1.87M derived: sum of 4 quarters · filed 2019-08-07 | |||||
| 2018-03-31 | $10.31K 10-Q · filed 2019-05-09 | $52.66K 10-Q · filed 2019-05-09 | $104.66K derived: sum of 3 quarters · filed 2019-05-09 | $209.75K derived: sum of 4 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | $42.35K 10-Q · filed 2019-02-07 | $94.34K derived: sum of 2 quarters · filed 2019-02-07 | $199.44K derived: sum of 3 quarters · filed 2019-02-07 | $2.27M derived: sum of 4 quarters · filed 2019-02-07 | |||||
| 2017-09-30 | $51.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $157.09K derived: sum of 2 quarters · filed 2019-01-25 | $2.23M derived: sum of 3 quarters · filed 2019-01-25 | $2.28M 10-K · filed 2019-01-25 | |||||
| 2017-06-30 | $105.09K 10-Q · filed 2018-08-09 | $2.17M derived: sum of 2 quarters · filed 2018-08-09 | $2.23M 10-Q · filed 2018-08-09 | $2.31M derived: sum of 4 quarters · filed 2019-01-25 | |||||
| 2017-03-31 | $2.07M 10-Q · filed 2018-05-10 | $2.12M 10-Q · filed 2018-05-10 | $2.20M derived: sum of 3 quarters · filed 2019-01-25 | $2.26M derived: sum of 4 quarters · filed 2019-01-25 | |||||
| 2016-12-31 | $53.02K 10-Q · filed 2018-02-07 | $130.77K derived: sum of 2 quarters · filed 2019-01-25 | $190.08K derived: sum of 3 quarters · filed 2019-01-25 | $339.44K derived: sum of 4 quarters · filed 2019-01-25 | |||||
| 2016-09-30 | $77.74K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $137.05K derived: sum of 2 quarters · filed 2019-01-25 | $286.42K derived: sum of 3 quarters · filed 2019-01-25 | $881.96K 10-K · filed 2019-01-25 | |||||
| 2016-06-30 | $59.31K 10-Q · filed 2017-08-07 | $208.68K derived: sum of 2 quarters · filed 2017-08-07 | $804.22K 10-Q · filed 2017-08-07 | -$585.36K derived: sum of 4 quarters · filed 2017-12-11 | |||||
| 2016-03-31 | $149.37K 10-Q · filed 2017-05-10 | $744.91K 10-Q · filed 2017-05-10 | -$644.66K derived: sum of 3 quarters · filed 2017-12-11 | -$3.37M derived: sum of 4 quarters · filed 2017-12-11 | |||||
| 2015-12-31 | $595.54K 10-Q · filed 2017-02-07 | -$794.03K derived: sum of 2 quarters · filed 2017-12-11 | -$3.52M derived: sum of 3 quarters · filed 2017-12-11 | -$4.39M derived: sum of 4 quarters · filed 2017-12-11 | |||||
| 2015-09-30 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | -$4.12M derived: sum of 2 quarters · filed 2017-12-11 | -$4.98M derived: sum of 3 quarters · filed 2017-12-11 | -$5.00M 10-K · filed 2017-12-11 | |||||
| 2015-06-30 | -$2.73M 10-Q · filed 2016-08-11 | -$3.59M derived: sum of 2 quarters · filed 2016-08-11 | -$3.61M 10-Q · filed 2016-08-11 | -$12.67M derived: sum of 4 quarters · filed 2016-12-14 | |||||
| 2015-03-31 | -$866.52K 10-Q · filed 2016-05-11 | -$882.56K 10-Q · filed 2016-05-11 | -$9.94M derived: sum of 3 quarters · filed 2016-12-14 | -$9.95M derived: sum of 4 quarters · filed 2016-12-14 | |||||
| 2014-12-31 | -$16.04K 10-Q · filed 2016-02-08 | -$9.08M derived: sum of 2 quarters · filed 2016-12-14 | -$9.09M derived: sum of 3 quarters · filed 2016-12-14 | -$9.08M derived: sum of 4 quarters · filed 2016-12-14 | |||||
| 2014-09-30 | -$9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | -$9.07M derived: sum of 2 quarters · filed 2016-12-14 | -$9.07M derived: sum of 3 quarters · filed 2016-12-14 | -$8.40M 10-K · filed 2016-12-14 | |||||
| 2014-06-30 | -$10.26K 10-Q · filed 2015-08-14 | -$7.95K derived: sum of 2 quarters · filed 2015-08-14 | $660.29K 10-Q · filed 2015-08-14 | -$859.80K derived: sum of 4 quarters · filed 2015-08-14 | |||||
| 2014-03-31 | $2.31K 10-Q · filed 2015-05-14 | $670.55K 10-Q · filed 2015-05-14 | -$849.55K derived: sum of 3 quarters · filed 2015-05-14 | -$875.49K derived: sum of 4 quarters · filed 2015-05-14 | -$9.96M 10-Q/A · filed 2014-05-30 | ||||
| 2013-12-31 | $668.25K 10-Q · filed 2015-02-17 | -$851.85K derived: sum of 2 quarters · filed 2015-02-17 | -$877.79K derived: sum of 3 quarters · filed 2015-02-17 | -$856.78K derived: sum of 4 quarters · filed 2015-02-17 | |||||
| 2013-09-30 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | -$1.55M derived: sum of 2 quarters · filed 2014-12-29 | -$1.53M derived: sum of 3 quarters · filed 2014-12-29 | -$1.56M 10-K · filed 2014-12-29 | |||||
| 2013-06-30 | -$25.94K 10-Q · filed 2014-08-13 | -$4.93K derived: sum of 2 quarters · filed 2014-08-13 | -$42.58K 10-Q · filed 2014-08-13 | ||||||
| 2013-03-31 | $21.01K 10-Q/A · filed 2014-05-30 | -$16.64K 10-Q/A · filed 2014-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |